pMSCVpuroATT逆病毒载体质粒图谱序列抗性-载体及构建-试剂-生物在线
Biovector Co.,LTD
pMSCVpuroATT逆病毒载体质粒图谱序列抗性

pMSCVpuroATT逆病毒载体质粒图谱序列抗性

商家询价

产品名称: pMSCVpuroATT逆病毒载体质粒图谱序列抗性

英文名称: pMSCVpuroATT逆病毒载体质粒图谱序列抗性说明书价格报价

产品编号: Biovector105802

产品价格: 0

产品产地: Biovector Inc. USA

品牌商标: Biovector, Addgene, ATCC, Invi

更新时间: null

使用范围: null

Biovector Co.,LTD
  • 联系人 :
  • 地址 : 北京市西直门外大街19号BioVector NTCC典型培养物保藏中心
  • 邮编 : 100080
  • 所在区域 : 北京
  • 电话 : 189****8599 点击查看
  • 传真 : 点击查看
  • 邮箱 : Biovector@163.com

pMSCVpuroATT 
(Plasmid #47539)

pMSCVpuroATT MCS
Add to Cart
Available to Academic and Nonprofits Only

BACKBONE

  • Vector backbone
    pMSCVpuro
  • Backbone manufacturer
    Clontech
  • Backbone size (bp)6300
  • Modifications to backbone
    Inserted Reading Frame Cassette A into the retroviral expression vector pMSCVpuro (Clontech) using the Gateway Vector Conversion System (Invitrogen)
  • Vector type
    Mammalian Expression, Retroviral
  • Selectable markers
    Puromycin

GROWTH IN BACTERIA

  • Bacterial Resistance(s)
    Ampicillin and Chloramphenicol
  • Growth Temperature
    37°C
  • Growth Strain(s)
    ccdB Survival
  • Copy number
    Unknown

SEQUENCE INFORMATION

  • Depositor Sequences
    None.
  • Addgene Sequences

Full plasmid sequence is available only if provided by the depositing laboratory.

CLONING INFORMATION

RESOURCE INFORMATION

  • Terms and Licenses
 
How to cite this plasmid

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pMSCVpuroATT was a gift from David Weinstock (Addgene plasmid # 47539)
  • For your References section:

    Next-generation cDNA screening for oncogene and resistance phenotypes. Shindoh N, Yoda A, Yoda Y, Sullivan TJ, Weigert O, Lane AA, Kopp N, Bird L, Rodig SJ, Fox EA, Weinstock DM. PLoS One. 2012;7(11):e49201. doi: 10.1371/journal.pone.0049201. Epub 2012 Nov 7. 10.1371/journal.pone.0049201 PubMed 23145123